Form 4 for BCRX BIOCRYST PHARMACEUTICALS INC
Accepted 2022-04-20 00:00:00 ET · period of report 2022-04-18 · accession 0001127602-22-012272 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-20 | 2022-04-18 | BCRX | ABERCROMBIE GEORGE B | Dir | S - Sale+OE | $11.04 | -5,000 | 0 | -100% | -$55.2K |
| D | 2022-04-20 | 2022-04-18 | BCRX | ABERCROMBIE GEORGE B | Dir | M - OptEx | $3.32 | +5,000 | 5,000 | New | +$16.6K |
| D | 2022-04-20 | 2022-04-18 | BCRX | ABERCROMBIE GEORGE B | Dir | M - OptEx | $0.00 | -5,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-18 | S | D | 5,000 | $11.04 | 0 | D | — | — | (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021. |
| 2 | Common | Common Stock | 2022-04-18 | M | A | 5,000 | $3.32 | 5,000 | D | — | — | (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021. |
| 3 | Derivative | Automatic Stock Option Grant | 2022-04-18 | M | D | 5,000 | $0.00 | 0 | D | $3.32 · — to 2022-05-23 | 5,000 Common Stock | (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021. (F2) The option vested 1/12 per month for a period of 12 months, beginning on June 23, 2012. |